Predictors of persistence and adherence to deutetrabenazine among patients with Huntington disease or tardive dyskinesia
{{output}}
Introduction: Deutetrabenazine is approved for treatment of Huntington disease (HD)-related chorea and tardive dyskinesia (TD) in adults. Factors associated with deutetrabenazine persistence and adherence are not well understood.... ...
